Critical Outcome Technologies Inc. Stock Other OTC
Equities
CA22675B1031
Biotechnology & Medical Research
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.2M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.47M | Net income 2019 | -2M -2.73M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.65K | Net cash position 2019 | 24.64K 33.67K | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |